DK3011059T3 - Biomarkør-identifikation - Google Patents
Biomarkør-identifikation Download PDFInfo
- Publication number
- DK3011059T3 DK3011059T3 DK14814334.0T DK14814334T DK3011059T3 DK 3011059 T3 DK3011059 T3 DK 3011059T3 DK 14814334 T DK14814334 T DK 14814334T DK 3011059 T3 DK3011059 T3 DK 3011059T3
- Authority
- DK
- Denmark
- Prior art keywords
- identification biomarker
- biomarker
- identification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013902243A AU2013902243A0 (en) | 2013-06-20 | Biomarker identification | |
| PCT/AU2014/050075 WO2014201516A2 (en) | 2013-06-20 | 2014-06-18 | Biomarker identification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3011059T3 true DK3011059T3 (da) | 2019-05-13 |
Family
ID=52105401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14814334.0T DK3011059T3 (da) | 2013-06-20 | 2014-06-18 | Biomarkør-identifikation |
Country Status (7)
| Country | Link |
|---|---|
| US (9) | US10190169B2 (da) |
| EP (1) | EP3011059B1 (da) |
| CN (1) | CN105518153A (da) |
| AU (1) | AU2014284124B2 (da) |
| CA (1) | CA2914193A1 (da) |
| DK (1) | DK3011059T3 (da) |
| WO (1) | WO2014201516A2 (da) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3011059T3 (da) | 2013-06-20 | 2019-05-13 | Immunexpress Pty Ltd | Biomarkør-identifikation |
| JP2017512304A (ja) * | 2014-02-06 | 2017-05-18 | イミューンエクスプレス・プロプライエタリー・リミテッドＩｍｍｕｎｅＸｐｒｅｓｓ Ｐｔｙ Ｌｔｄ | バイオマーカーシグネチャー法ならびにそのための装置およびキット |
| DK3117030T3 (da) * | 2014-03-14 | 2022-06-27 | Robert E W Hancock | Diagnosticering af sepsis |
| EP3253886A4 (en) * | 2015-02-03 | 2018-10-24 | The Trustees of the University of Pennsylvania | Novel methods for early identification of bone healing ability in injured patients |
| AU2016228508A1 (en) * | 2015-03-12 | 2017-09-07 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for diagnosis of sepsis |
| HK1249182A1 (zh) | 2015-05-28 | 2018-10-26 | Immunexpress Pty Ltd | 验证生物标志物测量 |
| CA2992139A1 (en) * | 2015-07-10 | 2017-01-19 | West Virginia University | Markers of stroke and stroke severity |
| CN108513586A (zh) * | 2015-09-30 | 2018-09-07 | 因姆内克斯普雷斯私人有限公司 | 病原体生物标志物及其用途 |
| DK3371324T3 (da) * | 2015-11-06 | 2021-11-15 | Immunexpress Pty Ltd | Virusbiomarkører og anvendelser deraf |
| WO2017173390A1 (en) * | 2016-03-31 | 2017-10-05 | Applied Proteomics, Inc. | Biomarker database generation and use |
| WO2017209426A1 (ko) * | 2016-06-02 | 2017-12-07 | 국립암센터 | Fam188b의 발현 억제제 또는 활성 억제제를 포함하는 항암 또는 항암보조제 조성물 |
| EP3475473A4 (en) | 2016-06-26 | 2020-01-22 | The Board of Trustees of the Leland Stanford Junior University | BIOMARKERS FOR PROGNOSING MORTALITY IN SERIOUSLY ILL PATIENTS |
| CN106148520A (zh) * | 2016-07-06 | 2016-11-23 | 西北工业大学 | Macf1基因及其表达产物在制备诊断和治疗骨质疏松症药物中的应用 |
| CN106202984B (zh) * | 2016-08-26 | 2018-09-04 | 赵毅 | 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法 |
| GB201616557D0 (en) * | 2016-09-29 | 2016-11-16 | Secretary Of State For Health The | Assay for distinguishing between sepsis and systemic inflammatory response syndrome |
| WO2018089442A2 (en) * | 2016-11-09 | 2018-05-17 | Intel IP Corporation | Ue and devices for detach handling |
| CN107034281B (zh) * | 2017-05-10 | 2020-10-20 | 甘肃农业大学 | 与甘肃高山细毛羊羊毛细度相关的遗传标记及其应用 |
| WO2018231772A1 (en) | 2017-06-13 | 2018-12-20 | Bostongene Corporation | Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy |
| US11028146B2 (en) * | 2017-09-22 | 2021-06-08 | Modern Meadow, Inc. | Recombinant yeast strains |
| DE102017126248B4 (de) | 2017-11-09 | 2019-10-17 | Epiontis Gmbh | ERGIC1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesonderemonozytischem myeloid-abgeleiteten Suppressor-Zellen (mMDSCs) |
| CN111836906A (zh) * | 2018-02-27 | 2020-10-27 | 斯坦福大学托管董事会 | 用于鉴定稳健型败血症亚型的分类器 |
| CN114908154A (zh) * | 2018-09-21 | 2022-08-16 | 王赞鑫 | 与主动脉夹层疾病相关的snp位点及其应用 |
| CN109512833B (zh) * | 2018-12-04 | 2020-10-30 | 天津医科大学总医院 | E2f6抑制剂的功能与用途 |
| US11104946B2 (en) * | 2019-04-23 | 2021-08-31 | Inflammatix, Inc. | DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome |
| CN110527727B (zh) * | 2019-07-05 | 2021-10-29 | 江苏医药职业学院 | 检测锌指蛋白28表达水平的试剂的应用和试剂盒 |
| CN110444254B (zh) * | 2019-07-08 | 2021-10-19 | 深圳先进技术研究院 | 一种菌群标记物的检测方法、检测系统及终端 |
| MX2022005633A (es) * | 2020-01-10 | 2022-06-14 | Sbi Biotech Co Ltd | Novedosos agonistas del receptor tipo toll 9 (tlr9). |
| CN111220799B (zh) * | 2020-03-29 | 2021-11-05 | 吉林大学 | Hsp90ab1蛋白在鉴定猪链球菌脑膜炎中的用途 |
| EP3896173A1 (en) * | 2020-04-17 | 2021-10-20 | Fundación Instituto de Estudios Ciencias de la Salud de Castilla y León (IECSCYL-IBSAL) | In vitro method for predicting mortality risk in patients suffering from infection with organ failure |
| FR3112211A1 (fr) * | 2020-07-06 | 2022-01-07 | bioMérieux | Procédé pour déterminer le risque de survenue d’une infection associée aux soins chez un patient |
| FR3112209A1 (fr) * | 2020-07-06 | 2022-01-07 | bioMérieux | Procédé pour déterminer le risque de complication chez un patient |
| FR3112207A1 (fr) * | 2020-07-06 | 2022-01-07 | bioMérieux | Procédé pour déterminer le risque de survenue d’une infection associée aux soins chez un patient |
| CN114487402A (zh) * | 2020-11-12 | 2022-05-13 | 首都医科大学附属北京世纪坛医院 | 尿液非分泌核糖核酸酶蛋白及其多肽片段在妊娠糖尿病中的应用 |
| CN113035298B (zh) * | 2021-04-02 | 2023-06-20 | 南京信息工程大学 | 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法 |
| CN113223618B (zh) * | 2021-05-26 | 2022-09-16 | 予果生物科技（北京）有限公司 | 基于宏基因组的临床重要致病菌毒力基因检测的方法及系统 |
| US20250188541A1 (en) * | 2021-08-30 | 2025-06-12 | The United States Government, As Represented By The Secretary Of The Army | Method of managing clinical outcomes from specific biomarkers in burn patients |
| CN114107487B (zh) * | 2021-12-23 | 2024-01-09 | 太原市精神病医院 | 一种可用于诊断脑卒中的产品 |
| CN114250294B (zh) * | 2021-12-23 | 2024-11-26 | 太原市精神病医院 | 可用于诊治脑卒中的标志物 |
| CN115044665A (zh) * | 2022-06-08 | 2022-09-13 | 中国人民解放军海军军医大学 | Arg1在制备脓毒症诊断、严重程度判断或预后评估试剂或试剂盒中的应用 |
| US20240018581A1 (en) * | 2022-07-15 | 2024-01-18 | Massachusetts Institute Of Technology | Mixture deconvolution method for identifying dna profiles |
| CN116298288A (zh) * | 2023-01-10 | 2023-06-23 | 复旦大学附属肿瘤医院 | Abcg1磷酸化位点作为肿瘤生物标记物的用途 |
| CN115896037B (zh) * | 2023-01-31 | 2024-12-27 | 深圳市人民医院 | 一种稳定敲除mettl7b基因的脑胶质瘤重组细胞及其构建方法 |
| WO2025024616A1 (en) * | 2023-07-24 | 2025-01-30 | Dot Laboratories, Inc. | Artificial intelligence methods and systems for determining endometriosis status |
| WO2025056769A1 (en) | 2023-09-14 | 2025-03-20 | Roche Diagnostics Gmbh | Method for assessing systemic inflammation |
| WO2025056737A1 (en) | 2023-09-14 | 2025-03-20 | F. Hoffmann-La Roche Ag | Classification method for classifying systemic inflammatory states |
| CN120758635B (zh) * | 2025-09-09 | 2025-12-30 | 宁波大学附属第一医院 | 急性髓系白血病的辅助诊断、预后诊断或危险度分层circRNA标记物及其应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI980488A7 (fi) | 1998-03-04 | 1999-09-05 | Arctic Partners Oy Ab | Uusi diagnostinen menetelmä |
| US7622260B2 (en) | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
| US20070134261A1 (en) * | 2001-12-03 | 2007-06-14 | Hancock Robert E | Effectors of innate immunity |
| WO2004044554A2 (en) * | 2002-11-12 | 2004-05-27 | Becton, Dickinson And Company | Diagnosis of sepsis or sirs using biomarker profiles |
| CN1742087A (zh) | 2002-11-12 | 2006-03-01 | 贝克顿迪金森公司 | 使用生物标记谱诊断脓毒或者sirs |
| AU2002952696A0 (en) | 2002-11-14 | 2002-11-28 | Genomics Research Partners Pty Ltd | Status determination |
| EP2366799A3 (de) | 2003-04-02 | 2012-06-20 | SIRS-Lab GmbH | Verfahren zur in vitro Erkennung schwerer Sepsis |
| EP2003196A3 (en) | 2003-06-09 | 2009-01-07 | The Regents of the University of Michigan | Compositions and methods for treating and diagnosing cancer |
| DE102004009952B4 (de) * | 2004-03-01 | 2011-06-01 | Sirs-Lab Gmbh | Verfahren zur Erkennung von Sepsis |
| CA2624601C (en) * | 2004-10-06 | 2018-07-03 | The Brigham And Women's Hospital, Inc. | Relevance of achieved levels of markers of systemic inflammation following treatment |
| EP1869463A4 (en) * | 2005-04-15 | 2010-05-05 | Becton Dickinson Co | SEPSIS DIAGNOSIS |
| AU2006259583A1 (en) | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| DE102005050933A1 (de) * | 2005-10-21 | 2007-04-26 | Justus-Liebig-Universität Giessen | Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen |
| ATE472611T1 (de) | 2005-11-25 | 2010-07-15 | Trinity College Dublin | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression |
| US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
| US20070255113A1 (en) | 2006-05-01 | 2007-11-01 | Grimes F R | Methods and apparatus for identifying disease status using biomarkers |
| US8450057B2 (en) | 2006-08-14 | 2013-05-28 | The Brigham And Women's Hospital, Inc. | Diagnostic tests using gene expression ratios |
| US20120082659A1 (en) * | 2007-10-02 | 2012-04-05 | Hartmut Land | Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations |
| DE102008000715B9 (de) * | 2008-03-17 | 2013-01-17 | Sirs-Lab Gmbh | Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen |
| EP2667194A3 (en) | 2009-01-14 | 2014-06-04 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Ratio based biomarkers and methods of use thereof |
| AU2010270313B2 (en) | 2009-07-10 | 2014-05-22 | Transgene Sa | Biomarker for selecting patients and related methods |
| US20110076685A1 (en) * | 2009-09-23 | 2011-03-31 | Sirs-Lab Gmbh | Method for in vitro detection and differentiation of pathophysiological conditions |
| US20110312521A1 (en) | 2010-06-17 | 2011-12-22 | Baylor Research Institute | Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases |
| US20140037649A1 (en) | 2010-11-26 | 2014-02-06 | Immunexpress Pty Ltd | Diagnostic and/or screening agents and uses therefor |
| EP2520662A1 (en) * | 2011-05-04 | 2012-11-07 | Stichting Sanquin Bloedvoorziening | Means and methods to determine a risk of multiple organ failure |
| AU2012308365A1 (en) | 2011-09-16 | 2014-04-24 | Cepheid | Methods of detecting sepsis |
| EP2931923A1 (en) | 2012-12-13 | 2015-10-21 | Baylor Research Institute | Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis |
| DK3011059T3 (da) | 2013-06-20 | 2019-05-13 | Immunexpress Pty Ltd | Biomarkør-identifikation |
| JP2017512304A (ja) | 2014-02-06 | 2017-05-18 | イミューンエクスプレス・プロプライエタリー・リミテッドＩｍｍｕｎｅＸｐｒｅｓｓ Ｐｔｙ Ｌｔｄ | バイオマーカーシグネチャー法ならびにそのための装置およびキット |
-
2014
- 2014-06-18 DK DK14814334.0T patent/DK3011059T3/da active
- 2014-06-18 CA CA2914193A patent/CA2914193A1/en not_active Abandoned
- 2014-06-18 EP EP14814334.0A patent/EP3011059B1/en active Active
- 2014-06-18 CN CN201480045616.9A patent/CN105518153A/zh active Pending
- 2014-06-18 WO PCT/AU2014/050075 patent/WO2014201516A2/en not_active Ceased
- 2014-06-18 AU AU2014284124A patent/AU2014284124B2/en active Active
- 2014-06-18 US US14/900,122 patent/US10190169B2/en active Active
-
2015
- 2015-05-15 US US14/714,182 patent/US20160055295A1/en not_active Abandoned
-
2016
- 2016-07-02 US US15/201,431 patent/US10167511B2/en active Active
-
2018
- 2018-11-08 US US16/184,873 patent/US10975437B2/en active Active
-
2020
- 2020-11-18 US US16/951,758 patent/US12006548B2/en active Active
-
2021
- 2021-09-22 US US17/481,622 patent/US20220243272A1/en not_active Abandoned
-
2024
- 2024-01-11 US US18/410,314 patent/US20240287607A1/en active Pending
-
2025
- 2025-06-20 US US19/244,969 patent/US20260015666A1/en active Pending
- 2025-06-20 US US19/244,972 patent/US20260015667A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3011059B1 (en) | 2019-02-06 |
| WO2014201516A3 (en) | 2015-02-19 |
| US10975437B2 (en) | 2021-04-13 |
| EP3011059A4 (en) | 2017-03-01 |
| US20160237493A1 (en) | 2016-08-18 |
| US20160055295A1 (en) | 2016-02-25 |
| US20160312286A1 (en) | 2016-10-27 |
| CN105518153A (zh) | 2016-04-20 |
| AU2014284124A1 (en) | 2015-12-17 |
| US20240287607A1 (en) | 2024-08-29 |
| US10167511B2 (en) | 2019-01-01 |
| EP3011059A2 (en) | 2016-04-27 |
| WO2014201516A2 (en) | 2014-12-24 |
| US20220243272A1 (en) | 2022-08-04 |
| US20260015667A1 (en) | 2026-01-15 |
| US20190330696A1 (en) | 2019-10-31 |
| US10190169B2 (en) | 2019-01-29 |
| US20260015666A1 (en) | 2026-01-15 |
| CA2914193A1 (en) | 2014-12-24 |
| US20210139991A1 (en) | 2021-05-13 |
| US12006548B2 (en) | 2024-06-11 |
| AU2014284124B2 (en) | 2020-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2022011I1 (no) | Tigolaner/Emodepsid/Praziquantel | |
| DK3011059T3 (da) | Biomarkør-identifikation | |
| DK3342773T3 (da) | Syk-hæmmere | |
| DK3613453T3 (da) | Fordamper | |
| UY4298S (es) | Carcasa | |
| DK3077047T3 (da) | Aramcholsalte | |
| DK3052081T3 (da) | Pastil | |
| DK3060460T3 (da) | Saddel | |
| DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
| DK2956698T5 (da) | Bindestrimler | |
| HRP20170953T1 (hr) | Sklop za identifikaciju identifikacijskog dokumenta | |
| DK2946640T3 (da) | Langmuir-probe | |
| EP2943489A4 (en) | DEUTERATED MOMELOTINIB | |
| DE102013106534B8 (de) | Chromatographiepipettenspitze | |
| EP2991647A4 (en) | DEUTERED AMLEXANOX | |
| EP2970310A4 (en) | 5-BROMO-indirubins | |
| EP2853297A4 (en) | kendama | |
| DK3071227T3 (da) | Fiskevaccine | |
| DE112014001252A5 (de) | Aufbissschiene | |
| DK3086679T3 (da) | Sportssko | |
| DK2981168T3 (da) | Laminitiskile | |
| FI10138U1 (fi) | Kelkkateltta | |
| ES1078715Y (es) | Mosquitera | |
| DE112014005422A5 (de) | Friktionsfalschdrallaggregat | |
| BR112016000501A2 (pt) | Nalador |